Although a larger cohort is necessary to confirm these findings, they nevertheless highlight the need for a comprehensive understanding of the of TERT dysregulation in AYA melanoma to develop prognostic assays for clinical risk stratification. The gene discussed is TERT; the disease is melanoma.